Keep me logged in for 24 hours

Register new account
I forgot my password

BAP Consensus Guidelines

Document Title Size Published
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Topic: Antidepressants
Co-Authors: Anthony Cleare, CM Pariante and AH Young. With expert co-authors (in alphabetical order): IM Anderson, D Christmas, PJ Cowen, C Dickens, IN Ferrier, J Geddes, S Gilbody, PM Haddad, C Katona, G Lewis, A Malizia, RH McAllister-Williams, P Ramchandani, J Scott, D Taylor, R Uher and the members of the
Show: full details
940 Kb 2015
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
Topic: Adult ADHD
Co-Authors: Blanca Bolea-Alamañac, David J Nutt, Marios Adamou, Phillip Asherson, Stephen Bazire, David Coghill, David Heal, Ulrich Müller, John Nash, Paramalah Santosh, Kapil Sayal, Edmund Sonuga- Barke and Susan J Young for the Consensus Group
Show: full details
397 Kb 2014
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Topic: Anxiety Disorder
Co-Authors: David S Baldwin, Ian M Anderson, David J Nutt, Christer Allgulander, Borwin Bandelow, Johan A den Boer, David M Christmas, Simon Davies, Naomi Fineberg, Nicky Lidbetter, Andrea Malizia, Paul McCrone, Daniel Nabarro, Catherine O’Neill, Jan Scott, Nic van der Wee and Hans-Ulrich Wittchen
Show: full details
683 Kb 2014
Benzodiazepines: Risks and benefits. A reconsideration
Topic: Benzodiazepines
Co-Authors: David S Baldwin, Katherine Aitchison, Alan Bateson, H Valerie Curran, Simon Davies, Brian Leonard, David J Nutt, David N Stephens and Sue Wilson
Show: full details
726 Kb 2013
Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology
Topic: Addiction
Co-Authors: AR Lingford-Hughes, S Welch, L Peters and DJ Nutt
Show: full details
1,134 Kb 2012
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Topic: Insomnia
Co-Authors: SJ Wilson, DJ Nutt, C Alford, SV Argyropoulos, DS Baldwin, AN Bateson, TC Britton, C Crowe, D-J Dijk, CA Espie, P Gringras, G Hajak, C Idzikowski, AD Krystal, JR Nash, H Selsick, AL Sharpley and AG Wade
Show: full details
752 Kb 2010
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from British Association for Psychopharmacology
Topic: Anti-Dementia Drugs
Co-Authors: A Burns and J O’Brien on behalf of the BAP Dementia Consensus Group
Show: full details
466 Kb 2010
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Topic: Schizophrenia
Co-Authors: Thomas R E Barnes and the Consensus Group
Show: full details
422 Kb 2010
Evidence-based Guidelines for Treating Bipolar Disorder
Topic: Bipolar Disorder
Co-Authors: GM Goodwin on behalf of the Consensus Group
Show: full details
645 Kb 2009

Latest News

Subscribe to the News Feed rss feed

  1. Summer Meeting 2015 - Review by Lancet Psychiatry
    on 3rd September 2015

    Joan Marsh from The Lancet reviews the 2015 Summer Meeting.
    Read Review
  2. Summer Meeting 2015 – Wednesday Symposium 9
    on 31st July 2015

    David Troy reports from Symposium 9 – 'Non-invasive Neurostimulation'
    Read Article
  3. Summer Meeting 2015 – Wednesday Symposium 8
    on 31st July 2015

    Abigail Moss attended Wednesday’s Symposium 8 – ‘The role of synaptic proteins in schizophrenia and related neurodevelopmental disorders’
    Read Report

See more news